Sartorius Corporation Reviews Fiscal 2013 Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The Sartorius Group (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, closed fiscal 2013 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Group CEO Dr. Joachim Kreuzburg emphasized that the company not only achieved all financial targets, but also has successfully moved forward with its Sartorius 2020 growth initiative: “In the Bioprocess Solutions Division, we further expanded our portfolio for the biopharma market by bolt-on acquisitions and own product development.

Help employers find you! Check out all the jobs and post your resume.